Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

NCT00966940 ·Status: COMPLETED ·Phase: PHASE4

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

NCT00637130 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Changing to DuoTrav From Prior Therapy

NCT01230736 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)

NCT00716742 ·Status: COMPLETED

Clinical Study Comparing Two Models of a Travoprost Intraocular Implant

NCT03868124 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of a Drug Delivery System in Glaucoma

NCT01016691 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

NCT00652496 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

NCT02097719 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Changing to DUOTRAV® From Prior Therapy

NCT01327599 ·Status: COMPLETED ·Phase: PHASE4

Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma

NCT01361841 ·Status: UNKNOWN ·Phase: NA

A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension

NCT00465803 ·Status: COMPLETED ·Phase: PHASE3

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293761 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

NCT01157364 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension

NCT01881126 ·Status: COMPLETED ·Phase: PHASE4

Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)

NCT01464424 ·Status: COMPLETED ·Phase: PHASE4

Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost

NCT00348400 ·Status: COMPLETED ·Phase: PHASE4

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

NCT00061503 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT02636946 ·Status: COMPLETED ·Phase: PHASE3

Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00872651 ·Status: COMPLETED ·Phase: PHASE3

Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%

NCT01452009 ·Status: WITHDRAWN ·Phase: PHASE3

Bimatoprost Versus Travoprost at Cairo University

NCT01092273 ·Status: COMPLETED

Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT01068964 ·Status: COMPLETED ·Phase: NA

Internet-based, Naturalistic Evaluation of Tolerability and Individual Patient Target Pressures With Bimatoprost 0.03% in Glaucoma

NCT00487214 ·Status: COMPLETED

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

NCT00329095 ·Status: COMPLETED ·Phase: PHASE4

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00672997 ·Status: COMPLETED ·Phase: PHASE3